Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eliana M C Tacconi

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Chromosoma|November 29, 2014
How homologous recombination maintains telomere integrityEliana M C Tacconi, Madalena Tarsounas
Oncotargets and Therapy|December 10, 2020
Review of Adjuvant Therapies in Renal Cell Carcinoma: Evidence to DateEliana M C Tacconi, Mark Tuthill, Andrew Protheroe
Nature Chemical Biology|September 8, 2014
A unique inhibitor binding site in ERK1/2 is associated with slow binding kineticsApirat Chaikuad, Eliana M C Tacconi, Jutta Zimmer, et al.
The Lancet. Healthy Longevity|July 28, 2024
The economic burden of cancer, coronary heart disease, dementia, and stroke in England in 2018, with projection to 2050: an evaluation of two cohort studiesFilipa Landeiro, Callum Harris, David Groves, et al.
Nature Communications|August 14, 2021
A transcription-based mechanism for oncogenic β-catenin-induced lethality in BRCA1/2-deficient cellsRebecca A Dagg, Gijs Zonderland, Emilia Puig Lombardi, et al.
Molecular Cell|January 11, 2016
Targeting BRCA1 and BRCA2 Deficiencies with G-Quadruplex-Interacting CompoundsJutta Zimmer, Eliana M C Tacconi, Cecilia Folio, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2019
Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinomaDaniel R McGowan, Michael Skwarski, Kevin M Bradley, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Chromosoma|November 29, 2014
How homologous recombination maintains telomere integrityEliana M C Tacconi, Madalena Tarsounas
Oncotargets and Therapy|December 10, 2020
Review of Adjuvant Therapies in Renal Cell Carcinoma: Evidence to DateEliana M C Tacconi, Mark Tuthill, Andrew Protheroe
Nature Chemical Biology|September 8, 2014
A unique inhibitor binding site in ERK1/2 is associated with slow binding kineticsApirat Chaikuad, Eliana M C Tacconi, Jutta Zimmer, et al.
The Lancet. Healthy Longevity|July 28, 2024
The economic burden of cancer, coronary heart disease, dementia, and stroke in England in 2018, with projection to 2050: an evaluation of two cohort studiesFilipa Landeiro, Callum Harris, David Groves, et al.
Nature Communications|August 14, 2021
A transcription-based mechanism for oncogenic β-catenin-induced lethality in BRCA1/2-deficient cellsRebecca A Dagg, Gijs Zonderland, Emilia Puig Lombardi, et al.
Molecular Cell|January 11, 2016
Targeting BRCA1 and BRCA2 Deficiencies with G-Quadruplex-Interacting CompoundsJutta Zimmer, Eliana M C Tacconi, Cecilia Folio, et al.
European Journal of Cancer (Oxford, England : 1990)|April 17, 2019
Buparlisib with thoracic radiotherapy and its effect on tumour hypoxia: A phase I study in patients with advanced non-small cell lung carcinomaDaniel R McGowan, Michael Skwarski, Kevin M Bradley, et al.
Pageof 1